Jacobson, J M <br/><br/>
Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group.  [electronic resource] 

 -  The Journal of infectious diseases  Jul 1999 
 - 61-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-1899 
<br/><br/><label>Standard No.: </label>10.1086/314834  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acquired Immunodeficiency Syndrome--complications<br/>Adult<br/>Antigens, CD--analysis<br/>Double-Blind Method<br/>Esophageal Diseases--complications<br/>Ethnicity<br/>Female<br/>HIV Infections--complications<br/>Humans<br/>Male<br/>Placebos<br/>Quality of Life<br/>Receptors, Tumor Necrosis Factor--analysis<br/>Receptors, Tumor Necrosis Factor, Type II<br/>Stomatitis, Aphthous--drug therapy<br/>Thalidomide--adverse effects<br/>Tumor Necrosis Factor-alpha--analysis<br/>Ulcer--complications<br/>United States